Sort
141,003 grants matching “cytokine”
Inflammation of Myofibroblasts and Loss of Elastic Recoil in Severe Asthma
$904,560Sally E Wenzel · University Of Pittsburgh At Pittsburgh · R01 · FY2010 · HL
Project 1 - Microglial activation in DNRAb-mediated brain pathology in mice
$904,394Bruce Thomas Volpe · Feinstein Institute For Medical Research · P01 · FY2023 · AI
Inflammation of Myofibroblasts and Loss of Elastic Recoil in Severe Asthma
$904,372Sally E Wenzel · University Of Pittsburgh At Pittsburgh · R01 · FY2006 · HL
Mechanisms of sphingolipid signaling in vascular health and disease
$904,366Timothy Tun Hla · Boston Children'S Hospital · R35 · FY2018 · HL
Computational and Experimental RNA Nanobiology
$904,278Bruce Shapiro · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA
Immune Regulation In Toxoplasmosis And Other Opportunistic Infections
$904,166Alan Sher · National Institute Of Allergy And Infectious Diseases · ZIA · FY2009 · AI
Preclinical Development of a Novel Gene Therapeutic for Inclusion Body Myositis
$904,058Buel Rodgers · Aavogen, Inc. · R44 · FY2022 · AG
Cytokines and T Cell Development
$904,000Scott Durum · Basic Sciences · Z01 · FY2007 · CA
Optimized Adaptation of Simian-tropic R5 HIV Clade C to Pig-tailed Macaques
$903,811Ruth Margrit Ruprecht · Texas Biomedical Research Institute · R56 · FY2013 · AI
Development of Vaccines to Prevent Tuberculosis
$903,787Robert A Seder · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI
Development of a novel renalase agonist for the treatment of acute pancreatitis
$903,732Eliot Ohlstein · Bessor Pharma, Llc · R44 · FY2025 · DK
Role of Oxidative Stress and Inflammation in HIV Cardiovascular Risk
$903,615Cecilia M Shikuma · University Of Hawaii At Manoa · R01 · FY2008 · HL
INHALED NO IN PREVENTION OF CHRONIC LUNG DISEASE
$903,335Childrens Hospital Of Philadelphia · U01 · FY2004 · HL
Steroids and Cross-linking for Ulcer Treatment (SCUT II)
$903,252Thomas M Lietman · University Of California, San Francisco · UG1 · FY2020 · EY
Preclinical Studies of Novel Anti-Diabetic Lipids
$903,077Barbara B Kahn · Beth Israel Deaconess Medical Center · R56 · FY2017 · DK
Modeling drugs of abuse-HIV interactions using iPSC-derived human cerebral organoids
$903,048Pietro P Sanna · Scripps Research Institute, The · R01 · FY2024 · DA
Modeling drugs of abuse-HIV interactions using iPSC-derived human cerebral organoids
$903,048Pietro P Sanna · Scripps Research Institute, The · R01 · FY2025 · DA
Cancer Immunotherapy Clinical Trials
$902,872Julius Strauss · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
PHASE II CLINICAL TRAIL - AN EXPLORATORY STUDY TO IDENTI
$902,847University Of Texas Md Anderson Can Ctr · N01 · FY2000 · CN
Preclinical Alzheimers Disease Drug Development of Novel MAPK Inhibitors
$902,779D. Martin Watterson · Northwestern University At Chicago · U01 · FY2013 · AG
Biocontainment Research Support Service(s) Core
$902,614Rachel M Olson · University Of Missouri-Columbia · UC7 · FY2025 · AI
ALZHEIMERS RESEARCH PROJECT: Alzheimer's disease drug development
$902,370Nigel H. Greig · National Institute On Aging · ZIA · FY2024 · AG
Clinical Research and Assay Support
$902,291Mary Walter · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIC · FY2020 · DK
Alternatively activated macrophages during type 2 immune responses
$902,045P'ng Loke · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI
Regulation of mucosal immune responses by helminth infections
$902,045P'ng Loke · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI